Home › Aldermeesklierkanker › Utah › Salt Lake City
Aldermeesklierkanker klinische studies in Salt Lake City, UT
15 studies voor Aldermeesklierkanker zoeken deelnemers op locaties in en rond Salt Lake City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruterenFase 1
- University of Utah - Huntsman Cancer Institute, Salt Lake City
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekruterenFase 3
- University of Utah, Huntsman Cancer Institute, Salt Lake City
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekruterenFase 3
- Investigative Site US053, Salt Lake City
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RekruterenFase 3
- Utah Cancer Specialists, Salt Lake City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekruterenFase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekruterenObservatieonderzoek
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Pancreatic Cancer Early Detection Consortium
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Huntsman Cancer Institute, Salt Lake City
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekruterenFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruterenFase 1/2
- Huntsman Cancer Institute, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekruteren
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekruterenFase 1/2
- Huntsman Cancer Institute, Salt Lake City
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekruterenFase 2
- Ohio State University-Telemedicine, Salt Lake City
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
RekruterenFase 1/2
- Huntsman Cancer Institute, Salt Lake City
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekruterenFase 1/2
- Utah Cancer Specialists (site 203), Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Salt Lake City
Aldermeesklierkanker studies in andere steden
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Philadelphia, PA26 studies
- Tampa, FL26 studies
- Durham, NC24 studies
Andere studies in Salt Lake City
- Niet-kleincellige longkanker31 studies
- Kanker (alle vormen)27 studies
- Borstkanker27 studies
- Colorectale kanker22 studies
- Longkanker21 studies
- Melanoom21 studies
- Multipel myeloom21 studies
- Metastatische kanker20 studies
- Eierstokkanker19 studies
- Obesitas18 studies
- Acute myeloïde leukemie17 studies
- Hartfalen17 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.